SNS851
Obesity / Metabolic Disease
Phase 1Active
Key Facts
About Oneness Biotech
Taiwanese biotech delivering Phase 3 wound‑care therapy and a diversified pipeline across dermatology, immunology and metabolism.
View full company profileTherapeutic Areas
Other Obesity / Metabolic Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed bLNP-Gene Therapy | BioGene Therapeutics | Preclinical |
| BMF-650 | Biomea Fusion | Preclinical |
| CLIC1 Inhibitor Program | ClicBio | Preclinical |